Bank Of Montreal Dynavax Technologies Corp Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Bank Of Montreal holds 236,471 shares of DVAX stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

236,471

Previous 1,082,180 78.15%

Holding current value

$2.43 Million

Previous $13.8 Million 77.81%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$12.39 - $14.4 $10.5 Million - $12.2 Million	-845,709 Reduced 78.15%	236,471 $3.07 Million
Q4 2024 Feb 13, 2025	BUY	$10.28 - $13.66 $52,417 - $69,652	5,099 Added 0.47%	1,082,180 $13.8 Million
Q3 2024 Nov 13, 2024	BUY	$10.05 - $11.61 $828,612 - $957,232	82,449 Added 8.29%	1,077,081 $12 Million
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $1.4 Million - $1.65 Million	130,893 Added 15.15%	994,632 $11.2 Million
Q1 2024 May 13, 2024	BUY	$11.7 - $14.98 $1.79 Million - $2.29 Million	152,625 Added 21.46%	863,739 $10.7 Million
Q4 2023 Feb 08, 2024	SELL	$13.09 - $14.98 $8.63 Million - $9.88 Million	-659,337 Reduced 48.11%	711,114 $9.94 Million
Q3 2023 Nov 01, 2023	BUY	$12.64 - $14.99 $9.29 Million - $11 Million	735,318 Added 115.77%	1,370,451 $20.2 Million
Q2 2023 Aug 02, 2023	BUY	$9.85 - $13.17 $2.18 Million - $2.91 Million	221,006 Added 53.37%	635,133 $8.21 Million
Q1 2023 Jun 13, 2024	SELL	$9.44 - $11.88 $1.42 Million - $1.79 Million	-150,907 Reduced 17.47%	712,832 $6.99 Million
Q4 2022 Feb 01, 2023	SELL	$10.27 - $13.29 $5.52 Million - $7.15 Million	-537,831 Reduced 56.5%	414,127 $4.41 Million
Q3 2022 Nov 10, 2022	SELL	$9.93 - $17.44 $7.07 Million - $12.4 Million	-712,179 Reduced 42.8%	951,958 $10.1 Million
Q2 2022 Aug 11, 2022	SELL	$7.45 - $12.83 $1.61 Million - $2.77 Million	-215,646 Reduced 11.47%	1,664,137 $21 Million
Q1 2022 May 12, 2022	BUY	$9.75 - $14.44 $2.53 Million - $3.74 Million	259,295 Added 16.0%	1,879,783 $20.7 Million
Q4 2021 Feb 11, 2022	BUY	$13.17 - $20.94 $17.3 Million - $27.4 Million	1,310,560 Added 422.86%	1,620,488 $23 Million
Q3 2021 Nov 12, 2021	SELL	$9.16 - $19.83 $2.18 Million - $4.72 Million	-238,072 Reduced 43.44%	309,928 $6.1 Million
Q2 2021 Aug 12, 2021	BUY	$7.25 - $10.99 $3.97 Million - $6.02 Million	548,000 New	548,000 $5.41 Million

Others Institutions Holding DVAX

# of Institutions

311

Shares Held

129M

Call Options Held

493K

Put Options Held

269K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.3B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account